Description
The medication Enablex (Darifenacin) is an extended-release tablet available in 7.5 mg or 15 mg strengths. The active ingredient‚ darifenacin‚ is a potent muscarinic receptor antagonist. Darifenacin hydrobromide is the chemical compound used in this medication. Enablex is commonly prescribed to treat symptoms of an overactive bladder.
Enablex Dosage and Administration
Enablex (Darifenacin) should be administered orally once daily with liquids‚ regardless of meals. The tablets should be swallowed whole and not chewed‚ divided‚ or crushed. The initial dosage for adults with symptoms of an overactive bladder is 7.5 mg once daily. Depending on the individual’s response to the medication‚ the dosage may be increased to 15 mg daily after a few weeks of starting therapy.
Dosage Forms and Strengths
Enablex extended-release tablets come in two strengths ౼ 7.5 mg and 15 mg. The 7.5 mg tablet is round‚ shallow‚ bi-convex‚ and white-colored‚ with ‘DF’ imprinted on one side and ‘7.5’ on the reverse. The 15 mg tablet is also an extended-release form of Darifenacin hydrobromide‚ designed to treat symptoms of an overactive bladder efficiently.
Indications
Enablex (Darifenacin) is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence‚ urgency‚ and frequency. It serves as a muscarinic antagonist‚ helping to alleviate symptoms of urinary frequency‚ urgency‚ and urge incontinence in individuals with overactive bladder conditions. The medication is recommended for adults experiencing these symptoms.
Contraindications
The use of Enablex (Darifenacin) is contraindicated in individuals with a history of allergies to darifenacin or any components of the medication. Patients with conditions such as uncontrolled narrow-angle glaucoma‚ issues related to urinary retention‚ or gastric retention should also avoid using Enablex. It is essential to inform the healthcare provider about any existing health conditions before starting treatment with Enablex.
Drug Interactions
When considering the usage of Enablex (Darifenacin)‚ it is essential to be aware of potential drug interactions that could affect its effectiveness or increase the risk of side effects. Some notable drug interactions include the potential interaction between Enablex and anticholinergic agents‚ as well as the impact of concomitant use of potent CYP3A4 inhibitors. Patients should inform their healthcare provider about all medications they are taking‚ including over-the-counter drugs‚ herbal supplements‚ and prescription medications‚ to avoid any potential drug interactions that could impact the efficacy of Enablex.
Administration Instructions
When administering Enablex (Darifenacin)‚ it is crucial to follow specific instructions for optimal efficacy and safety. The medication should be taken orally once daily with liquids‚ irrespective of meals. It is imperative to swallow the tablets whole and avoid chewing‚ dividing‚ or crushing them. It is recommended to start with an initial dosage of 7.5 mg daily for adults with overactive bladder symptoms‚ followed by potential adjustment to a 15 mg daily dose based on individual response.
Storage Information
Enablex (Darifenacin) should be stored at a temperature not exceeding 25°C (77°F) with excursions allowed between 15°C to 30°C (59°F to 86°F). It is important to protect the medication from light exposure to maintain its stability and effectiveness. Keep Enablex in its original packaging and away from moisture or heat sources.
Leave a Reply